@article{ACS16920,
author = {Marc de Perrot and Karen McRae and Laura Donahoe and Etienne Abdelnour-Berchtold and John Thenganatt and John Granton},
title = {Pulmonary endarterectomy in severe chronic thromboembolic pulmonary hypertension: the Toronto experience},
journal = {Annals of Cardiothoracic Surgery},
volume = {11},
number = {2},
year = {2022},
keywords = {},
abstract = {Background: Pulmonary endarterectomy (PEA) in severe chronic thromboembolic pulmonary hypertension (CTEPH) is associated with higher risks. However, recent evidence suggests that these risks may be mitigated with the use of extracorporeal membrane oxygenation (ECMO).
Methods: We performed a retrospective analysis of 401 consecutive patients undergoing PEA at the Toronto General Hospital between August 2005 and March 2020. Patients with severe CTEPH defined by pulmonary vascular resistance (PVR) >1,000 dynes.s.cm–5 at the time of diagnosis were compared to those with PVR 1,000 dynes.s.cm–5. A greater proportion of patients with PVR >1,000 dynes.s.cm–5 was treated with targeted pulmonary hypertension (PH) medical therapy (38% vs. 18%, P},
issn = {2304-1021}, url = {https://www.annalscts.com/article/view/16920}
}